Sara Gilgore

Vanda Pharmaceuticals’ motion sickness drug has finally hit the market after years of setbacks.

A Florida physical therapy company backed by private equity has snapped up another practice in Greater Washington.

United Health Services wants to shift control of a future stand-alone ER project in Ward 7 to GWU Hospital.

A D.C.-area biotech is selling its drug substance manufacturing business and its Rockville headquarters building so it can focus on R&D.

Johns Hopkins Medicine’s two D.C.-area hospitals will shut down a pair of home healthcare companies this summer.

Johns Hopkins Medicine’s two D.C.-area hospitals will shut down a pair of home healthcare companies this summer.

A publicly traded medical marijuana company had been gearing up for a big Virginia expansion. That changed Tuesday when Gov. Spanberger vetoed a bill that would have create a recreational cannabis market.

A McLean health-tech company focused on medical cannabis has set the terms of a forthcoming IPO, making it the latest in a string of public debuts.

UHS has reached a deal with GW University and its nonprofit physician network to form a new medical group that would replace the existing one, under a new structure.

Bowie State University President Aminta Breaux is making some tough decisions to put Maryland’s oldest historically Black college on firmer financial footing.